Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia cell O157:H7 outbreak

Lancet

Volumn 354, Issue 9187, 1999, Pages 1327-1330

  Dundas, S ^a   Murphy, J ^a   Soutar, R L ^a   Jones, G A ^b   Hutchinson, S J ^c   Todd, W T A ^a  

^a MONKLANDS HOSPITAL   (United Kingdom)

^b DUMFRIES AND GALLOWAY ROYAL INFIRMARY   (United Kingdom)

^c Scottish Centre for Infection and Environmental Health   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; PROSTACYCLIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DEATH; DEMOGRAPHY; DISEASE SEVERITY; ESCHERICHIA COLI O157; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MORTALITY; NEUROLOGIC DISEASE; PLASMAPHERESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 0033576164     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)01251-9     Document Type: Article

References (25)

1. Riley L.W., Remis R.S., Helgerson S.D. Haemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med. 308:1983;681-685.
2. Armstrong G.L., Hollingsworth J., Morris J.G. Emerging foodborne pathogens: Escherichia coli O157:H7 model of entry of a new pathogen into the food supply of the developed world. Epidemiol Rev. 18:1996;29-51.
3. Reilly W.J. E coli O157 in Scotland - an overview. SCIEH Wkly Rep. 97:1997;4-5.
4. Dundas, S., Todd, W.T.A., Stewart, A.I., Chaudhuri, A.K.R., Murdoch, P.S. The central Scotland 1996 Escherichia coli O157 outbreak: predictors of haemolytic uraemic syndrome/thrombotic thrombocytopaenic purpura and death (in press).
5. Griffin P.M., Olmstead L.C., Petras R.E. Escherichia coli O157:H7-associated colitis. Gastroenterology. 99:1990;142-149.
6. Morris K.P., Coulthard M.G., Rangecroft L. Oesophageal and severe gut involvement in the haemolytic uraemic syndrome. Br J Surg. 78:1991;1469-1472.
7. Karmali M.A., Petric M., Corazon L., Fleming P.C., Arbus G.S., Loir H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis. 151:1985;775-782.
8. Thrombotic thrombocytopaenic purpura associated with Escherichia coli O157:H7-Washington. MMWR Morb Mortal Wkly Rep 1986; 35: 549-51.
9. Tesh V.L., O'Brien A.D. The pathogenetic mechanisms of shiga toxin and the shiga-like toxins. Mol Microbiol. 5:1991;1817-1822.
10. Drummond K. Haemolytic uraemic syndrome - then and now. N Engl J Med. 312:1985;116-118.
11. Duncan L., Carter A., Carlson J., Borczyk A., Karmali M. Outbreak of gastrointestinal disease in Sarnia, Ontario. Ontario. Ontario Dis Surveillance Rep. 7:1986;604-610.
12. Cimolai N., Carter J.E., Morrison B.J., Anderson J.D. Risk factors for the progression of Escherichia coli O157:H7 enteritis to the hemolytic uremic syndrome. J Pediatr. 116:1990;589-592.
13. Carter A.O., Borczyk A.A., Carlson J.A.C., Harvey B., Hockin J.C., Karmali M.A. A severe outbreak of Escerichia coli O157:H7-associated haemorrhagic colitis in a nursing home. N Engl J Med. 24:1987;1496-1500.
14. Walters M.S., Matthei I.U., Kay R., Dhillon M.J. The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome. Pediatr Nephrol. 3:1989;130-134.
15. Rock G.A., Shumak K.H., Buskard N.A.et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med. 325:1991;393-397.
16. Ruggenenti P., Lutz J., Remuzzi G. Pathogenesis and treatment of thrombotic microangiopathy. Kidney Int. 51:1997;97-101.
17. Karch H., Janetzki-Mittmaann C., Aleksic S., Datz M. Isolation of enterohaemorrhagic Escherichia coli O157 strains from patients with haemolytic-uraemic syndrome by using immunomagnetic separation, DNA-based methods, and direct culture. J Clin Microbiol. 34:1996;516-519.
18. Rock G., Shumar K.H., Sutton D.M.C., Buskard N.A., Nair R.C. Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Br J Haematol. 94:1996;383-386.
19. Petit R.M. Thrombotic thrombocytopaenic purpura: a thirty-year review. Semin Thromb Hemost. 6:1980;350-355.
20. Mead P.S., Griffin P.M. Escherichia coli O157:H7. Lancet. 352:1988;1207-1212.
21. Begue R.E., Mehta D.I., Blecker U. Escherichia coli and the hemolytic-uremic syndrome. South Med J. 91:1998;798-804.
22. Hughes D.A., Beattie T.J., Murphy A.V. Haemolytic uraemic syndrome: 17 years experience in a Scottish paediatric renal unit. Scott Med J. 36:1991;9-12.
23. McBrien A.D., Lively T.A., Chen M.E., Rothman S., Formal F.B. Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a shigella dysenteriae 1 (Shiga) like cytotoxin. Lancet. i:1983;702.
24. Lousi C.B., Obrig T.G. Shiga toxin-associated hemolytic uremic syndrome: Combined cytotoxic effects of Shiga toxin, interleukin 1β, and tumour necrosis factor alpha on human vascular endothelial cells in vitro. Infect Immun. 59:1991;4173-4179.
25. Moake J.L., McPherson P.D. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Am J Med. 87:1989;3-151.